Multisite Biventricular Pacing to Treat Refractory Heart Failure: Why and How?

  • J. C. Daubert
  • C. Leclercq
  • C. Alonso
  • P. Mabo
Conference paper


Despite pharmacological advances, in particular the introduction of ACE inhibitors and ß-blockers, the prognosis of patients with severe heart failure (grades III and IV of the NYHA classification) remains pejorative and their quality of life is poor. A number of nonpharmacological treatments have been proposed for this type of patients: heart transplantation remains the reference treatment although its application is restricted by donor shortage, among other factors. Left ventricular (LV) support devices are still at the evaluation stage and the results of cardiomyoplasty are highly controversial. In the early 1990s, standard dual-chamber pacing with short AV delay was proposed as a supplementary treatment for drug-resistant heart failure. Initial results were encouraging but were never confirmed. These studies, however, made it possible to select a population of potentially responsive patients, especially those with a prolonged PR interval reflecting major atrioventricular asynchrony in the left heart. That relative failure of standard dual-chamber pacing could be linked to the fact that by capturing the ventricle from the right apex, it increases, or at least it cannot correct the marked asynchrony of activation, contraction and relaxation which characterizes a number of patients with chronic LV dysfunction. Such is the case in particular in patients with important QRS enlargement linked to major intraventricular conduction delay. Biventricular pacing, which simultaneously activates both ventricles, may contribute to correcting the asynchrony and thus improve cardiac performance.


Biventricular Pace Left Ventricular Lead Left Ventricular Pace Conduction Disorder Pulmonary Capillary Pressure 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WilenskyRL, Yudelman P, Cohen AI et al (1988) Serial electrocardiographicchanges in idiopathic dilatedcardiomyopathy confirmed at necropsy. Am J Cardiol 62:276–283PubMedCrossRefGoogle Scholar
  2. 2.
    XiaoH, Roy C, Fujimoto S, Gibson D (1996) Natural history of abnormal conductionand its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol53:163–170PubMedCrossRefGoogle Scholar
  3. 3.
    Schoeller R, Andresen D, Büttner P, Oezcelik K, Vey G, SchröderR (1993) First or seconddegree atrioventricular block as a risk factor in idiopathic dilatedcardiomyopathy. Am J Cardiol 71:720–726PubMedCrossRefGoogle Scholar
  4. 4.
    CowburnP, Cleland J, Coast A, Komajda M (1998) Risk stratification in chronic heartfailure. Eur Heart J 19:696–710PubMedCrossRefGoogle Scholar
  5. 5.
    Aaronson K, Schwartz S, Chen T, Wong K, Goin J, Mancini D(1997) Development and prospectivevalidation of a clinical index to predict survival in ambulatory patientsreferred for cardiac transplant evaluation. Circulation 95:2660–2667PubMedCrossRefGoogle Scholar
  6. 6.
    SilvermanM, Pressel M, Brackett J, Lauria S, Gold M, Gottlieb S (1995) Prognostic valueof the signal-averaged electrocardiogram and a prolonged QRS in ischemic andnon ischemic cardiomyopathy. Am J Cardiol 75:460–464PubMedCrossRefGoogle Scholar
  7. 7.
    LikoffM, Chandler S, Kay H (1987) Clinical determinants of mortality in chroniccongestive heart failure secondary to idiopathic dilated or to ischemiccardiomyopathy. Am J Cardiol 59:634PubMedCrossRefGoogle Scholar
  8. 8.
    Nishimura RA, Hayes DL, Holmes DR Jr, Tajik AJ (1995)Mechanism of hemodynamic improvementby dual-chamber pacing for severe left ventricular dysfunction: an acuteDoppler and catheterization study. J Am Coll Cardiol 25:281–288PubMedCrossRefGoogle Scholar
  9. 9.
    ScanuP, Lecluze E, Michel L et al (1996) Effects of temporal Dual-Chamber cardiacpacing in refractory cardiac failure. Arch Mal Coeur 89:1643–1649PubMedGoogle Scholar
  10. 10.
    Hamby R, Weissman R, Prakash M, Hoffman I (1983) Left bundle branch block: apredictor of poor left ventricular function in coronary artery disease. AmHeart J 106:471–477Google Scholar
  11. 11.
    Murkofsky R, Dangas G, Diamond J, Mehta D, Schaffer A, Ambrose J (1998) A prolonged QRSduration on surface ECG is a specific indicator of left ventriculardysfunction. J Am Coll Cardiol 32:476–482PubMedCrossRefGoogle Scholar
  12. 12.
    XiaoHB, Roy C, Gibson DG (1994) Nature of ventricular activation in patients withdilated cardiomyopathy: evidence for bilateral bundle branch block. Br Heart J72:167–174CrossRefGoogle Scholar
  13. 13.
    XiaoHB, Brecker SJD, Gibson DG (1992) Effect of abnormal activation on the timecourse of the left ventricular pressure pulse in dilated cardiomyopathy. BrHeart J 68:403–407Google Scholar
  14. 14.
    KonoT, Sabbah H, Rosman H, Alam M, Jaffri S, Goldstein S (1998) Left ventricularshape is the primary determinant of functional mitral regurgitation in heartfailure. J Am Coll Cardiol 7:1594–1598Google Scholar
  15. 15.
    BoltwoodC, Tei C Wong M, Shah P(1983) Quantitative echocardiography of the mitralcomplex in dilated cardiomyopathy: the mechanism of functional mitralregurgitation. Circulation 68:498–508PubMedCrossRefGoogle Scholar
  16. 16.
    Panidis I, Ross J, Munley B, Nestico P, Mintz G (1986)Diastolic mitral regurgitation in patients with atrioventricularconduction abnormalities: a common finding by doppler echocardiography. J AmColl Cardiol 7:768–774CrossRefGoogle Scholar
  17. 17.
    Appelton C, Basnignht M, Gonzalez M, Carucci M, Henry C,Olajos M (1991) diastolic mitralregurgitation with atrioventricular conduction abnormalities: relation ofmitral flow velocity to transmitral pressure gradients in conscious dogs. J AmColl Cardiol 18:843–849CrossRefGoogle Scholar
  18. 18.
    IshikawaT, Sumita S, Kimura K et al (1994) Critical PQ interval for the appearance ofdiastolic mitral regurgitation and optimal PQ interval in patients implantedwith DDD pacemakers. PACE 17:1989–1994PubMedCrossRefGoogle Scholar
  19. 19.
    Foster AH, Gold MR, McLaughlin JS (1995) Acute hemodynamic effects ofatriobiventricular pacing in humans. Ann Thorac Surg 59:294–300PubMedCrossRefGoogle Scholar
  20. 20.
    CazeauS, RitterP,Lazarus A etal(1996) Multisite pacing for end-stage heart failure: early experience. PACE 19(part II): 1748–1757PubMedCrossRefGoogle Scholar
  21. 21.
    LeclercqC, Cazeau S, Le Breton H et al (1998) Acute hemodynamic effects ofbiventricular DDD pacing in patients with end-stage heart failure. J Am CollCardiol 32:1825–1831CrossRefGoogle Scholar
  22. 22.
    BlancJJ, Etienne Y, Gilard M et al (1997) Evaluation of different ventricular pacingsites in patients with severe heart failure. Circulation 96:3273–3277PubMedCrossRefGoogle Scholar
  23. 23.
    KassDA, Chen CH, Curry et al (1999) Improved left ventricular mechanics fromacute VDD pacing in patients with dilated cardiomyopathy and intraventricularconduction delay. Circulation 99:1567–1573PubMedCrossRefGoogle Scholar
  24. 24.
    LeclercqC, Cazeau S, Victor F et al (1998) Long-term results of permanentbiventricular pacing in refractory heart failure: comparison between class IIIand class IV patients. Eur Heart J 19:573Google Scholar
  25. 25.
    SaxonL, Kerwin W, Cahalan M et al (1998) Acute effects of intraoperative multisteventricular pacing on left ventricular function and activation/contractionsequence in patients with depressed ventricular function. J CardiovascElectrophysiol 9:13–21CrossRefGoogle Scholar
  26. 26.
    AuricchioA, Stellbrink C, Sack S et al (1999) The pacing therapies for congestive heartfailure (PATH-CHF) study: rationale, design and endpoints of a prospectiverandomized multicenter study. Am J Cardiol 83:D130–D135CrossRefGoogle Scholar
  27. 27.
    AuricchioA, Klein H, Tockman B et al (1999) Transvenous biventricular pacing for heartfailure: can the obstacles be overcome? Am J Cardiol 83:D136–D142CrossRefGoogle Scholar
  28. 28.
    DaubertJC, RitterP,Le Breton H etal(1998) Permanent left ventricular pacing with transvenous leads inserted intothe coronary veins. PACE 21:239–245PubMedCrossRefGoogle Scholar
  29. 29.
    Blanc JJ, Benditt DG, Gilard M, Etienne Y, Mansourati J,Lurie K (1998) A method for permanent transvenous left ventricular pacing. PACE21: 2021–2024PubMedCrossRefGoogle Scholar
  30. 30.
    Jaïs P, Douard H, Shah DC, Barold S, BaratJL, Clémenty J (1998) Endocardial biventricular pacing. PACE21:2128–2131PubMedCrossRefGoogle Scholar
  31. 31.
    Alonso C, Leclercq C, Mansour H et al (1999) ECG-predicting factors oflong-term improvement with multisite biventricular pacing in advanced heartfailure. PACE 22:758 (abstr)Google Scholar
  32. 32.
    Cazeau S, RitterP,Bakdachs etal(1994) Four chamber pacing in dilated cardiomyopathy. PACE 17:1974–1979PubMedCrossRefGoogle Scholar
  33. 33.
    DaubertC, Leclercq C, Pavin D, Mabo P (1996) Biatrral synchronous pacing: a newapproach to prevent arrhythmia in patients with atrial conduction block. In:Daubert C, Prystowsky E, Ripart A (eds) Prevention of tachyarrhythmias withcardiac pacing. Futura, Armonk, NY, pp 99–119Google Scholar
  34. 34.
    GrasD,Mabo P, TangT et al (1998)Multisite pacing as a supplemental treatment of congestive heart failure:preliminary results of the Medtronic Inc. In Sync study. PACE 21:2249–2255PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • J. C. Daubert
    • 1
  • C. Leclercq
    • 1
  • C. Alonso
    • 1
  • P. Mabo
    • 1
  1. 1.Département de Cardiologie et Maladies Vasculaires, Centre Cardio-PneumologiqueHôpital Pontchaillou CHURennesFrance

Personalised recommendations